PTSD Symptoms
7
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
Open-Label Psilocybin Study in Transdiagnostic Population
Clinician Supported Mobile App to Reduce Mental Health Symptoms Among World Trade Center Responders in Florida
Cannabis, Neuroinflammation, and Suicidal Ideation: A Supplemental Brain Imaging Study
Virtual Reality Treatment for Trauma Related to COVID-19 Infection
Integrative Exercise for Post-Deployment Stress
Comparing Acupuncture, BioModulator, and Transcutaneous Electrical Nerve Stimulation for Symptomatic Treatment of Chronic Pain.